| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c70a73c92196ebd45af3dc0dd616432b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f77c6ab7824da2c5be321982a17db00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7a4bcb0c1052c69a3ebb0ae9b0578d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_879e07d5c36a7f1528c2c7f568a5413a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_387f9129a76dd2b9bd12cd9c0bdcedfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e304ec1a97a46e4e940a1a0b36780a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f145d971f6e930a984893ce2088f8748 |
| publicationDate |
2016-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2572948-T3 |
| titleOfInvention |
Rotigotine compositions or pharmaceutically acceptable salts of rotigotine |
| abstract |
A microsphere composition comprising rotigotine or a pharmaceutically acceptable salt thereof; at least one poly (lactide-co-glycolide) (PLGA); and at least one fatty acid, in which the rotigotine or its pharmaceutical salt thereof is 20-40%, the at least one PLGA is 57.5-72.5% and the at least one fatty acid is the 2.5-7.5% by weight with respect to the total weight of the composition. |
| priorityDate |
2010-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |